Burning Rock Biotech (BNR) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Burning Rock Biotech (BNR) has outperformed Precipio (PRPO) over the past year, gaining 80.5% versus a gain of 17.6%. Over five years, PRPO leads with a -54.8% price change compared with -89.2% for BNR. Burning Rock Biotech is the larger company by market cap ($163.4 million vs $41.4 million), about 3.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNR | PRPO |
|---|---|---|
| Share price | $15.49 | $23.12 |
| Market cap | $163.36M | $41.39M |
| 1-day change | +3.27% | -0.30% |
| YTD return | -23.13% | +0.61% |
| 1-year return | +80.54% | +17.60% |
| 5-year return | -89.21% | -54.84% |
| Forward P/E | — | 59.28 |
| EPS (TTM) | $-0.80 | $-0.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $41.72 | $33.63 |
| 52-week low | $6.79 | $16.40 |
| Distance from 52-week high | -62.87% | -31.25% |
| Average volume | 28.31K | 125.71K |
| Shares outstanding | 8.81M | 1.79M |
| Employees | 667 | 61 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Burning Rock Biotech is about 3.9 times larger than Precipio by market value ($163.36M vs $41.39M).
- BNR has outperformed PRPO by 62.9 percentage points over the past year.
- The two companies sit in different sectors: Burning Rock Biotech in Health Care and Precipio in Industrials.
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 61 employees
BNR vs PRPO FAQ
Which is bigger, Burning Rock Biotech or Precipio?
Burning Rock Biotech (BNR) is larger, with a market capitalization of $163.36M compared with $41.39M for Precipio (PRPO).
Which stock has performed better over the past year, BNR or PRPO?
BNR returned +80.54% over the past 12 months, compared with +17.60% for PRPO (price return, excluding dividends). Past performance does not predict future results.
Are Burning Rock Biotech and Precipio in the same industry?
No. Burning Rock Biotech is in the Health Care sector, while Precipio is in Industrials.